This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
home-builder: Archive
Is Schwab International Core Equity (SICNX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for SICNX
SICNXPositive Net Change
equity home-builder mutual-funds
Is T. Rowe Price Retirement Balanced (TRRIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for TRRIX
TRRIXPositive Net Change
equity home-builder mutual-funds
Should You Buy AppFolio (APPF) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
APPFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
F.N.B. (FNB)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
FNBNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Amgen (AMGN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
AMGNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Franklin Natural Resources A (FRNRX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FRNRX
FRNRXNegative Net Change
equity home-builder mutual-funds
Is T. Rowe Price Personal Strategy Growth (TRSGX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for TRSGX
TRSGXPositive Net Change
equity home-builder mutual-funds
Is Schwab MarketTrack Growth Investor (SWHGX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for SWHGX
SWHGXPositive Net Change
equity home-builder mutual-funds
Is Glenmede Disciplined US Eq (GTLOX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for GTLOX
GTLOXPositive Net Change
equity home-builder mutual-funds
Is Baron Emerging Markets Retail (BEXFX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for BEXFX
BEXFXPositive Net Change
equity home-builder mutual-funds
Should You Buy Alphabet Inc. (GOOG) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
GOOGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is American Funds Mutual Fund A (AMRMX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for AMRMX
AMRMXPositive Net Change
equity home-builder mutual-funds
Is Invesco SteelPath MLP Income A (MLPDX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for MLPDX
MLPDXNegative Net Change
equity home-builder mutual-funds
Is American Funds New Economy F2 (NEFFX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for NEFFX
NEFFXPositive Net Change
equity home-builder mutual-funds
Is Fidelity Balanced Fund K (FBAKX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FBAKX
FBAKXNegative Net Change
equity home-builder mutual-funds
Raymond James Financial, Inc. (RJF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
RJFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
CryoPort, Inc. (CYRX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CYRXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Alphabet (GOOGL) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
GOOGLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Ur Energy (URG) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
URGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Envista (NVST)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
NVSTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Franklin Growth A (FKGRX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FKGRX
FKGRXNegative Net Change
equity home-builder mutual-funds
Is Fidelity Overseas Fund (FOSFX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FOSFX
FOSFXPositive Net Change
equity home-builder mutual-funds
Is Macquarie Small Cap Growth Y (WSCYX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for WSCYX
WSCYXPositive Net Change
equity home-builder mutual-funds
Is Fidelity Advisor New Insights I (FINSX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FINSX
FINSXNegative Net Change
equity home-builder mutual-funds
NVR's Q2 Earnings & Homebuilding Revenues Top, New Orders Down Y/Y
by Zacks Equity Research
NVR tops Q2 estimates on higher ASPs, but new orders fell 11% as affordability issues and cancellations rise.
PHMNegative Net Change KBHNegative Net Change DHINegative Net Change NVRNegative Net Change
construction earnings home-builder